Anti-ATG7 antibody [EPR6251]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(16 Reviews)
|
(123 Publications)
Rabbit Recombinant Monoclonal ATG7 antibody. Suitable for WB, ICC/IF and reacts with Rat, Human, Mouse samples. Cited in 123 publications.
View Alternative Names
APG7L, ATG7, Ubiquitin-like modifier-activating enzyme ATG7, ATG12-activating enzyme E1 ATG7, Autophagy-related protein 7, Ubiquitin-activating enzyme E1-like protein, APG7-like, hAGP7
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATG7 antibody [EPR6251] (AB133528)
Immunocytochemistry/Immunofluorescence analysis of HT-29 (Human colorectal adenocarcinoma cell line) labeling ATG7 with purified ab133528 at 1/500 dilution. Cells were fixed with 100% methanol. ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) at 1/1000 was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-ATG7 antibody [EPR6251] (AB133528)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling ATG7 with purified ab133528 at 1/150 dilution (8.5μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1/1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Lab
Western blot - Anti-ATG7 antibody [EPR6251] (AB133528)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATG7 antibody [EPR6251] (ab133528) at 1/50000 dilution
Lane 1:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 2:
Mouse spleen lysate at 20 µg
Lane 3:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 4:
Mouse kidney lysate at 20 µg
Lane 5:
Rat kidney lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa,77 kDa
Observed band size: 47 kDa,77 kDa
false
- WB
Lab
Western blot - Anti-ATG7 antibody [EPR6251] (AB133528)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : ATG7 knockout HAP1 cell lysate (20 μg)
Lane 3 : Jurkat cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133528 observed at 77 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab133528 was shown to specifically react with ATG7 when ATG7 knockout samples were used. Wild-type and Apg7 knockout samples were subjected to SDS-PAGE. ab133528 and ab8245 (loading control to GAPDH) were diluted 1/10,000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-ATG7 antibody [EPR6251] (ab133528)
Predicted band size: 77 kDa
false
- WB
Lab
Western blot - Anti-ATG7 antibody [EPR6251] (AB133528)
False colour image of Western blot : Anti-ATG7 antibody [EPR6251] staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab133528 was shown to bind specifically to ATG7. A band was observed at 75 kDa in wild-type HeLa cell lysates with no signal observed at this size in ATG7 knockout cell line ab283307 (knockout cell lysate ab287353). To generate this image, wild-type and ATG7 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ATG7 antibody [EPR6251] (ab133528) at 1/10000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ATG7 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ATG7 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-atg7-knockout-hela-cell-line-ab283307'>ab283307</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 77 kDa
Observed band size: 75 kDa
false
- WB
Lab
Western blot - Anti-ATG7 antibody [EPR6251] (AB133528)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATG7 antibody [EPR6251] (ab133528) at 1/10000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Rat spleen lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 77 kDa
Observed band size: 77 kDa
false
Related conjugates and formulations (2)
-
Anti-ATG7 antibody [EPR6251] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ATG7 antibody [EPR6251]
Reactivity data
Product details
We have had 1 attempt at IHC-P with ab133528 in our own lab. We observed both cytoplasmic and nuclear staining on several tissues (including human stomach, kidney and pancreatic cancer), under our experimental conditions. For IHC-P on human tissues, we would recommend using ab52472.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATG7 plays a significant role in autophagy a cellular degradation pathway critical for cell survival under stress. ATG7 contributes to the formation of autophagosomes by facilitating conjugation of ATG8 family proteins including LC3 to phosphatidylethanolamine. It acts within complexes that regulate cellular energy balance and stress responses ensuring cells maintain their function and integrity. Knockdown of ATG7 can impair autophagic flux highlighting its importance in maintaining cellular processes.
Pathways
ATG7 is a central player in the autophagy pathway influencing cellular metabolism and turnover. It interacts closely with ATG5 and ATG12 in this pathway to form a conjugation system essential for autophagosome elongation. Additionally ATG7 is involved in the mTOR signaling pathway which regulates nutrient sensing and cellular growth. Interaction with proteins like mTOR allows ATG7 to integrate signals from nutrient availability and stress responses finely tuning the autophagy process.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (123)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5964 PubMed40593716
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:130 PubMed40000633
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1504583 PubMed39944686
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:1107 PubMed39774185
2025
Applications
Unspecified application
Species
Unspecified reactive species
Islets 16:2429854 PubMed39541216
2024
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 25:349 PubMed39342213
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 24:785 PubMed38997686
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 57:e13702 PubMed38956970
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 40:631-641 PubMed38826147
2024
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 9: PubMed38652543
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com